References
- Sadarangani M, Seaton C, Scott JAG, et al. Incidence and outcome of convulsive status epilepticus in Kenyan children: a cohort study. Lancet Neurol. 2008;7(2):145–150.
- Chin RFM, Neville BGR, Peckham C, et al. Incidence, cause, and short-term outcome of convulsive status epilepticus in childhood: prospective population-based study. Lancet Lond Engl. 2006;368(9531):222–229.
- Kumar M, Kumari R, Narain NP. Clinical profile of status epilepticus (SE) in children in a tertiary care hospital in Bihar. J Clin Diagn Res. 2014;8(7):PC14–7.
- Nabbout R, Vezzani A, Dulac O, et al. Acute encephalopathy with inflammation-mediated status epilepticus. Lancet Neurol. 2011;10(1):99–108.
- Lothman EW, Bertram EH. Epileptogenic effects of status epilepticus. Epilepsia. 1993;34(suppl 1):S59–S70.
- Raspall-Chaure M, Chin RFM, Neville BG, et al. Outcome of paediatric convulsive status epilepticus: a systematic review. Lancet Neurol. 2006;5(9):769–779.
- Alkhachroum A, Der-Nigoghossian CA, Rubinos C, et al. Markers in status epilepticus prognosis. J Clin Neurophysiol. 2020;37(5):422–428.
- Brindley E, Hill TDM, Henshall DC. MicroRNAs as biomarkers and treatment targets in status epilepticus. Epilepsy Behav. 2019;101(Pt B):106272.
- Engel J, Pitkänen A, Loeb JA, et al. Epilepsy biomarkers. Epilepsia. 2013;54 Suppl 4:61–69.
- Süssmuth SD, Reiber H, Tumani H. Tau protein in cerebrospinal fluid (CSF): a blood-CSF barrier related evaluation in patients with various neurological diseases. Neurosci Lett. 2001;300(2):95–98.
- Monti G, Tondelli M, Giovannini G, et al. Cerebrospinal fluid tau proteins in status epilepticus. Epilepsy Behav. 2015;49:150–154.
- Shahim P, Rejdak R, Ksiazek P, et al. Cerebrospinal fluid biomarkers of β-amyloid metabolism and neuronal damage in epileptic seizures. Eur J Neurol. 2014;21(3):486–491.
- The WHO Child GrowthStandards [Internet]. [cited 2021 Jan 22]. Available from: https://www.who.int/tools/child-growth-standards/standards.
- Trinka E, Cock H, Hesdorffer D, et al. A definition and classification of status epilepticus—report of the ILAE Task Force on Classification of Status Epilepticus. Epilepsia. 2015;56(10):1515–1523.
- Beers SR, Wisniewski SR, Garcia-Filion P, et al. Validity of a pediatric version of the glasgow outcome scale–extended. J Neurotrauma. 2012;29(6):1126–1139.
- Palmio J, Suhonen J, Keränen T, et al. Cerebrospinal fluid tau as a marker of neuronal damage after epileptic seizure. Seizure. 2009;18(7):474–477.
- Shahim P, Darin N, Andreasson U, et al. Cerebrospinal fluid brain injury biomarkers in children: a multicenter study. Pediatr Neurol. 2013;49(1):31–39.e2.
- Datta D, Conroy AL, Castelluccio PF, et al. Elevated cerebrospinal fluid tau protein concentrations on admission are associated with long-term neurologic and cognitive impairment in Ugandan children with cerebral malaria. Clin Infect Dis. 2020;70(6):1161–1168.
- Medana IM, Idro R, Newton CRJC. Axonal and astrocyte injury markers in the cerebrospinal fluid of Kenyan children with severe malaria. J Neurol Sci. 2007;258(1–2):93–98.